Cardiotoxicity Assessment of EGFR Tyrosine Kinase Inhibitors Using Human iPS Cell‐Derived Cardiomyocytes and FDA Adverse Events Reporting System by Shota Yanagida, Hiroyuki Kawagishi, Mitsuo Saito, Hirofumi Hamano, Yoshito Zamami, Yasunari Kanda

Get full text

Fractures Associated with Immune Checkpoint Inhibitors: A Disproportionality Analysis of the World Health Organization Pharmacovigilance Database by Takenao Koseki, Hirofumi Hamano, Masakazu Hatano, Takao Tobe, Ryo Ieda, Tsuyoshi Nakai, Yoshito Zamami, Shigeki Yamada

Get full text

Trends in nontuberculous mycobacterial disease mortality based on 2000-2022 data from 83 countries by Ko Harada, Quynh Thi Vu, Yoshito Nishimura, Tatsuaki Takeda, Hirofumi Hamano, Yusuke Minato, Yoshito Zamami, Toshihiro Koyama, Hideharu Hagiya

Get full text

Time dependent predictors of cardiac inflammatory adverse events in cancer patients receiving immune checkpoint inhibitors by Michael Sayer, Hirofumi Hamano, Misako Nagasaka, Benjamin J. Lee, Jean Doh, Pranav M. Patel, Yoshito Zamami, Aya F. Ozaki

Get full text

Incidence and survival outcomes of myocarditis and pericardial diseases associated with immune checkpoint inhibitor therapy by Aya F. Ozaki, Michael Sayer, Hirofumi Hamano, Misako Nagasaka, Benjamin J. Lee, Jean Doh, Ali Naqvi, Nareh Nowrouzi, Yoshito Zamami, Pranav M. Patel

Get full text

Global trends in mortality related to pulmonary embolism: an epidemiological analysis of data from the World Health Organization mortality database from 2001 to 2023Research in con... by Hideharu Hagiya, Ko Harada, Yoshito Nishimura, Maki Yamamoto, Sayoko Nishimura, Michio Yamamoto, Takahiro Niimura, Yuka Osaki, Quynh Thi Vu, Mariko Fujii, Nanami Sako, Tatsuaki Takeda, Hirofumi Hamano, Yoshito Zamami, Toshihiro Koyama

Get full text